Gastrointestinal Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 386 Deals Signed Since 2016 by the World's Leading Life Science Companies and Universities
September 25, 2024 09:15 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Gastrointestinal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated,...
Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
September 25, 2024 08:16 ET
|
Spherix Global Insights
EXTON, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm, is expanding its specialized offerings to buy-side financial firms...
Compact C-Arm Market to Reach $714.1 Million, Globally, by 2033 at 5.7% CAGR: Allied Market Research
September 23, 2024 10:56 ET
|
Allied Analytics LLP
Wilmington, Delaware, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Compact C-Arm Market by Technology (Fluoroscopy Systems and Flat Detector Systems),...
Despite Projections of a 2024 Adalimumab Biosimilar Boom, Humira Remains Dominant for Now, According to Spherix Global Insights
September 23, 2024 10:18 ET
|
Spherix Global Insights
EXTON, PA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights compiled data from their RealTime Dynamix™ services in Crohn’s Disease, Rheumatoid Arthritis, and Psoriasis, fielded in late...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
September 20, 2024 07:45 ET
|
Regeneron Pharmaceuticals, Inc.
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements seen in...
Ipsen's Iqirvo Shows Strong Start in Primary Biliary Cholangitis, Now Faces Rivalry from Gilead's Livdelzi
August 29, 2024 14:14 ET
|
Spherix Global Insights
EXTON, PA, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The past few months have ushered in a new era of treatment for patients suffering from primary biliary cholangitis (PBC), marked by the approval of...
Dr. Babusai Rapaka Joins Gastroenterology Consultants of San Antonio
August 29, 2024 08:20 ET
|
GI Alliance
San Antonio, TX, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Gastroenterology Consultants of San Antonio is proud to welcome Dr. Babusai Rapaka, a board-certified gastroenterologist who treats all...
Dr. James Haddad Joins Texas Digestive Disease Consultants in McKinney
August 27, 2024 08:20 ET
|
GI Alliance
McKinney, TX, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Texas Digestive Disease Consultants is proud to welcome Dr. James Haddad, a board-certified gastroenterologist who treats all GI issues while...
Dr. Shams Tabrez Joins GI Alliance in Willow Park
August 26, 2024 08:20 ET
|
GI Alliance
Willow Park, TX, Aug. 26, 2024 (GLOBE NEWSWIRE) -- GI Alliance is proud to welcome Dr. Shams Tabrez, a board certified gastroenterologist who treats all GI disease while specializing in liver...
Dr. Brittany Mitchell Joins Washington Gastroenterology in Silverdale
August 23, 2024 10:15 ET
|
GI Alliance
Silverdale, WA, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Washington Gastroenterology is proud to welcome Dr. Brittany Mitchell, a board-certified gastroenterologist who treats all general GI conditions...